Mono‐, di or trinuclear dioxouranium complexes with benzoylhydrazonato or azomethine ligands were prepared by reactions of common dioxouranium precursors such as UO 2 (NO 3 ) 2 · 6 H 2 O or [NBu 4 ] 2 [UO 2 Cl 4 ] with vanillin benzoylhydrazone (H 2 L 4 ), salicylaldehyde benzoylhydrazone (H 2 L 5 ), 2‐hydroxyacetylbenzene salicylhydrazone (H 3 L 6 ) or N‐(2‐ethoxycarbonyl‐3‐oxo‐but‐1‐en(1)yl)‐2‐aminophenol (H 2 L 7 ). Spectroscopic and X‐ray crystallographic studies on the complexes [NBu 4 ] 2 [UO 2 Cl 4 ] · 2 H 2 L 4 , [UO 2 (HL 5 )(H 2 L 5 ) 2 ](NO 3 ), [HNEt 3 ] 2 [{UO 2 (L 6 )} 2 ] and [HNEt 3 ] 2 [{UO 2 (L 7 } 3 O] confirm that the individual donor atom constellation, the size of the potential chelate rings and the acidity of the OH and NH functionalities of the proligands have a strong influence on the structure of the products.
No takes yet. Share an insight, caveat, or question.
Gatto et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: